Isracann Biosciences are positioned nicely to capitalise on the weed industries future growth.
Worth a read into.
This is a buy IMO, confirmed by chart after breakout if you like technical analysis. Gap to fill for first target.
GL
Bullish Pennant
Pros:
Descending volume during formation
Golden cross in blue
PPS above 50MA and 200MA
RS above 0, and ascending
ATR Ascending
R/R ratio above 4
200MA ascending
250RSI below 50
If confirmed:
PT = 0.50$